Greencamp

APRIL 23, 2019

Canada is one of the countries with the highest numbers of MS patients. For patients who don’t respond well to conventional MS methods, cannabis treatment seems like a very reasonable choice. However, not all patients respond to these treatments well enough, and some don’t respond at all. Here’s whether cannabis can help.

Research and Development 94

Research and Development Strains Patients Treatment 94

Canna Care Docs

DECEMBER 11, 2018

A study published in the journal, Chemistry & Biodiversity , noted “marked improvement” in the quality of sleep in patients with chronic pain problems. [5] “Cannabis And Pain: A Clinical Review” Cannabis And Cannabinoid Research 2 (1): 96-104. Here, too, cannabis has been shown to have a distinct effect. Geoffrey W.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Freedom Leaf

JANUARY 10, 2018

Tikun Olam , which was founded in 2007, controls nearly 40% of the Israeli medical-marijuana market. Under the Israeli program, patients must commit to a single cannabis producer. Hence, companies like Tikun Olam are able to find out exactly what their patients need based on their ailments, and create medicine accordingly.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

CannaMD

JULY 21, 2020

Many of these compounds are classified as cannabinoids. There are two major cannabinoids, and chances are you’ve heard of them already: CBD and THC. In addition to cannabinoids (like THC and CBD), there are terpenes (compounds that produce a strong odor), flavonoids (plant metabolites with antioxidant effects), and more.

Chronic Pain 52

Chronic Pain Marijuana Cannabinoids Medicine 52

Veriheal

FEBRUARY 28, 2021

The last day of February, the 28th, or the 29th during a leap year is World Rare Disease Day and this day has been designated to help bring awareness to rare diseases as well as the impact they have on patients and their lives. Patients and family members are open to trying anything that might help.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

The Cannigma

AUGUST 26, 2021

This represents nearly double the level of support found in a 2007 survey (21%). The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Green Relief

FEBRUARY 20, 2018

The ECS deficiency state often results from a perfect storm of individual gene mutations negatively influencing ECS receptors, along with lacking intake of vital cannabinoid nutrients (ie: cannabis). Immune system pathways (for targeted cannabinoid therapy) 12. Vitamin d3/gcmaf (ECS receptors affected) 10. 2002 Feb-Mar;66(2-3):143-60.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

FEBRUARY 19, 2018

The ECS deficiency state often results from a perfect storm of individual gene mutations negatively influencing ECS receptors, along with lacking intake of vital cannabinoid nutrients (ie: cannabis). Immune system pathways (for targeted cannabinoid therapy) 12. Vitamin d3/gcmaf (ECS receptors affected) 10. 2002 Feb-Mar;66(2-3):143-60.

Therapy 40

Therapy Cannabinoids Terpenes Pharmaceutical 40

Otherside Farms

MAY 5, 2021

With a vaporizer, you have an effective way to continue heating the herbs to a temperature that’s high enough to extract the CBD, THC, or the other cannabinoids. 40% of patients’ pain is reduced when they use marijuana. 40% of patients’ pain is reduced when they use marijuana.

Vaping 52

Vaping THC Oil Chronic Pain 52

Greenspoon Marder Cannabis Law Group Blog

JANUARY 22, 2020

However, MMCs could only sell hemp or CBD products to their medical marijuana patients. 173 (2007), also known as The “CHAMP” Case. Under a prior law, Colorado’s retail cannabis businesses were prohibited from selling “non-marijuana consumable products,” which included hemp products. v Commissioner, 128 T.C.

Retail 40

Retail Hemp Seed-To-Sale Business 40

The Cannigma

APRIL 7, 2022

I was going to live at a place he was buying an Eagle Rock and this guy from Berkeley came in, Don Duncan, who had helped start Berkeley Patients Group and was going to open up LAPCG in Los Angeles. I mean, we’re just discovering the TRP Channels that are involved in maybe the headache effects of cannabinoids. Just for reference.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

SpeedWeed

JULY 29, 2021

In vaporization, a heating mechanism heats cannabis oil to activate cannabinoids and terpenes. Past that, DaVinci’s IQ series devices come with a smartphone app that lets you personalize your session down to the exact ratio of THC and CBD you’re taking in, a necessary tool for medical cannabis patients. The history of vaporizers.

Vaping 40

Vaping Terpenes Oil History 40

Corante

FEBRUARY 26, 2020

The potency of the crop is dependent on several factors, including the interaction between the terpenes, cannabinoids, and flavonoids of the strain. This was made possible as a result of the legalization of medical marijuana and the foundation of medical marijuana testing laboratories.

Strains 40

Strains CBD Hemp THC 40

Cannabis Law Report

JUNE 11, 2019

A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. Just because another case finds marihuana useful for one patient does not automatically infer that it is medically necessary for another plaintiff. A significant award for Nabilone, the synthetic cannabinoid, was allowed in this case.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Otherside Farms

JANUARY 23, 2019

1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus (full – 1974). Anticancer activity of cannabinoids (full – 1975). BOT] Anticancer activity of cannabinoids (Journal of the National Cancer Institute, Vol. Antineoplastic activity of cannabinoids (full – 1975).

Oil 75

Oil Cannabinoids Medicine Treatment 75

Greencamp

DECEMBER 4, 2018

Nonetheless, the available collection of scientific work confirms that consuming cannabis-derived cannabinoids (phytocannabinoids) compels our body to produce more (endo)cannabinoid receptors, but also to create more endocannabinoids. These receptors are located on the membranes of many different cells, spread throughot the body.

Cannabinoids 107

Cannabinoids Research and Development Conditions THC 107

Otherside Farms

JANUARY 23, 2019

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.

Cannabinoids 72

Cannabinoids Treatment Therapy Research and Development 72

Kind Meds (Cannabis Education Blog)

APRIL 25, 2022

The first known use of marijuana to treat medical conditions within patients was cited in China in the third millennium BCE. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. 2] Tambaro, S., & Bortolato, M. 3] Aggarwal, S. 3] Aggarwal, S.

Strains 98

Strains Marijuana Sativa Hybrid 98

Greencamp

NOVEMBER 9, 2018

In this article we’ll investigate the science behind using cannabis with asthma, patients’ experiences with the plant and the best methods to get medicated if you’re suffering from asthma. Usually, if patients avoid things that trigger their symptoms and take their medications regularly, keeping the condition under control is not an issue.

Research and Development 92

Research and Development Edibles Patients Cannabinoids 92

Cannabis Law Report

JANUARY 23, 2022

ciency illnesses, congenital metabolic defects, hemoglobinopathies, and myelodysplastic and myeloproliferative syndromes (Weisdorf, 2007). GVHD affects a significant portion of transplant patients, anywhere between 30% and 70% of patients depending on how closely the donor’s tissue matches with the patient.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

United Patients Group

APRIL 18, 2023

The truth is that it’s impossible to fatally overdose on marijuana alone, as a study in the American Journal of Public Health found no deaths reported due to cannabis use between 1999 and 2007. The US federal government even owns a patent on cannabinoids for use as a neuroprotectant! Click here to view.

Research and Development 116

Research and Development Indica Treatment Conditions 116

Cannabis Law Report

OCTOBER 29, 2019

Routine nonsteroidal anti-inflammatory drug (NSAID) treatments, though efficacious, may not provide adequate relief of pain due to osteoarthritis (OA) and might have potential side effects that preclude its use, particularly in geriatric patients with certain comorbidities, such as kidney or gastrointestinal pathologies ( 1 – 4 ).

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

FEBRUARY 1, 2020

There are now over 1,000 registered patients receiving medical marijuana products by prescription, and this number is projected to surge to 400,000 by 2028. Given single Australians under 35 years old spend about A$849/week total, such high expenditures on marijuana could amount to 25%+ of an epileptic patient’s monthly budget.

Legalization 59

Legalization Research and Development Recreational Access 59

Weedistry

MARCH 7, 2019

Mounting evidence shows cannabinoids in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find.

THC 40

THC CBD Clinical Trials Research and Development 40

CannaMD

JULY 8, 2020

The authors note that marijuana cannabinoids, THC and CBD , appear to have antidepressant-like effects in animal models, and report that in human surveys: Medical cannabis users perceived a 50% reduction in depression and a 58% reduction in anxiety and stress following cannabis use. Depression, Anxiety, and Stress.

Marijuana 111

Marijuana Research and Development Conditions THC 111

SpeedWeed

FEBRUARY 19, 2021

Egyptian medical applications of cannabis show an astute knowledge of the efficacy of herbal remedies, and virtually all of their remedies containing it utilize it in a way in which cannabis has been known to be medically effective (Russo, 2006/2007). Both eyes of the patient are to be washed with it in the morning.”.

Research and Development 52

Research and Development Cannabis Hemp Concentrates 52

Cannabis Law Report

MARCH 25, 2019

It is worth noting that Marinol ® (dronabinol) is an FDA-approved synthetic cannabinoid that was placed in Schedule III under the CSA in 1999.). 2003, 2004, 2007, 2008, Nov. 2003, 2004, 2007, 2008, Nov. The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. 101–189, div.

Banking 45

Banking Law Marijuana State Laws 45